Navigation Links
PAREXEL International to Present at Robert Baird 2009 Healthcare Conference
Date:9/1/2009

BOSTON, Sept. 1 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL) announced today it will be presenting at the Robert Baird 2009 Healthcare Conference in New York, NY. James F. Winschel, Jr., Senior Vice President and Chief Financial Officer will be making a formal presentation on PAREXEL at 10:30 a.m. EDT on Wednesday, September 9, 2009.

A live webcast of this presentation will be available under the "Upcoming Events" section on PAREXEL's "Investors" homepage at www.PAREXEL.com. A replay of the presentation will be available until November 24, 2009.

About the Company

PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 70 locations throughout 52 countries around the world, and has over 9,275 employees. For more information about PAREXEL International visit www.parexel.com.

PAREXEL is a registered trademark of PAREXEL International Corporation, and Perceptive Informatics is a trademark of Perceptive Informatics, Inc. All other names or marks may be registered trademarks or trademarks of their respective business and are hereby acknowledged.

    CONTACT:  Jill Baker, Vice President of Investor Relations
              +1-781-434-4118


'/>"/>
SOURCE PAREXEL International Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2009 Earnings Release and Conference Call
2. PAREXEL International to Present at the Wachovia Equity Conference
3. PAREXEL Experts to Present Leading Insights at Drug Information Association 45th Annual Meeting
4. PAREXEL Consulting Experts To Present Insights Into Achieving Regulatory Approval at the 2009 BIO International Convention
5. PAREXEL Reports Third Quarter Fiscal Year 2009 Financial Results
6. PAREXEL Receives BioSingapore Award for Best Performing CRO
7. PAREXEL Experts to Address Benefits of Rigorous Early Phase Development at Annual ASCPT Meeting
8. PAREXEL Expert to Address Value of Incorporating Asia Into Global Clinical Development at BioMedical Asia 2009
9. PAREXEL Experts to Present Leading Insights at Drug Information Association 21st Annual Euromeeting
10. PAREXEL Appoints Josephine Hoppe to Chief Information Officer
11. PAREXEL International to Present at the 27th Annual JP Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... and SAN DIEGO , Dec. ... the appointment of Santosh Kesari , MD, PhD, ... will leverage his experience in neurology and clinical trials ... stem cell for treatment of stroke. The AmnioStem product is ... which has previously shown therapeutic activity in animal models ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... and development of precision treatments for neurodegenerative diseases, today announced the validated ... inhibited the direct neurotoxic effect of prion-like forms of Amyloid beta (Aß) ...
(Date:12/5/2016)... Research and Markets has announced the addition of Jain ... to their offering. ... , This report describes different ... as proteomics and metabolomics. Molecular diagnostics technologies are used for the ... Currently the most important applications of biomarkers are in ...
(Date:12/5/2016)... 5, 2016  Renova™ Therapeutics, a biotechnology company ... and other chronic diseases, announced that Catherine ... Chief Financial Officer (CFO), effective today. ... of experience in financial management for a variety ... companies. Most recently, Ms. Bovenizer was the Vice ...
Breaking Biology Technology:
(Date:12/2/2016)... December 1, 2016 The ... Voice), Future Technology (Iris Recognition System), Vehicle Type ... Global Forecast to 2021", published by MarketsandMarkets, the ... in 2016, and is projected to grow to ... of 14.06%.      (Logo: http://photos.prnewswire.com/prnh/20160303/792302) ...
(Date:11/29/2016)... , Nov. 29, 2016 BioDirection, a privately ... products for the objective detection of concussion and other ... has successfully completed a meeting with the U.S. Food ... blood test Pre-Submission Package. During the meeting company representatives ... as a precursor to commencement of a planned pilot ...
(Date:11/24/2016)... , Nov. 23, 2016 Cercacor today introduced ... and their trainers non-invasively measure hemoglobin, Oxygen ... Rate, and Respiration Rate in approximately 30 seconds. Smaller ... easy and immediate access to key data about their ... a training regimen. Hemoglobin carries oxygen ...
Breaking Biology News(10 mins):